Article

A plasma proteomic signature for atherosclerotic cardiovascular disease risk prediction in the UK Biobank cohort

2024-09-15

Abstract excerpt

<h4>Background</h4> While risk stratification for atherosclerotic cardiovascular disease (ASCVD) is essential for primary prevention, current clinical risk algorithms demonstrate variability and leave room for further improvement. The plasma proteome holds promise as a future diagnostic and prognostic tool that can accurately reflect complex human traits and disease processes. We assessed the ability of plasma pr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ce31fc08-4287-5177-b56d-212204d44ff0
DOI: 10.1101/2024.09.13.24313652

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A plasma proteomic signature for atherosclerotic cardiovascular disease risk prediction in the UK Biobank cohortDOI 10.1101/2024.09.13.24313652Read

Proteomic Signatures as Biomarkers of Atherosclerosis BurdenSemantic proximity Read

Proteomic analysis identifies lipoprotein(a)-associated proteins linked to incident atherosclerotic cardiovascular disease eventsSemantic proximity Read

Sex-specific proteomic signatures improve cardiovascular risk prediction for the general population without cardiovascular disease or diabetesSemantic proximity Read

Plasma proteomic signatures for type 2 diabetes mellitus and related traits in the UK Biobank cohortSemantic proximity Read

Proteome-wide Mendelian randomization identifies candidate causal proteins for cardiovascular diseasesSemantic proximity Read

Blood plasma proteome-wide association study implicates novel proteins in the pathogenesis of multiple cardiovascular diseases.Semantic proximity Read

Machine Learning-Driven Prediction of Coronary Artery Disease Risk Based on UK Biobank Plasma Proteomics.Semantic proximity Read

Plasma Proteomic Profiles Predict the Risk of Coronary Artery Disease in the UK Biobank CohortSemantic proximity Read

Large-scale evaluation of proteomic and polygenic risk scores reveals complementary contributions to incident disease predictionSemantic proximity Read

Machine learning-guided deconvolution of plasma protein levelsSemantic proximity Read

Risk prediction of ischemic heart disease using plasma proteomics, conventional risk factors and polygenic scores in Chinese and European adultsSemantic proximity Read

Plasma proteomic architecture of incident valvular heart disease in the UK Biobank: discovery, genetic prioritization, and exploratory risk discriminationSemantic proximity Read